We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 26 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

  1. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  2. マーケットリサーチセンター Tokyo//Service Industry
  3. ケーナインラボ Tokyo//Testing, Analysis and Measurement
  4. 4 null/null
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. K9 Lab Inc. Company Profile ケーナインラボ
  3. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  4. 4 Pharmaceutical CDMO services 大塚化学
  5. 4 Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン

medicine Product List

1～15 item / All 533 items

Displayed results
Tateyama Kasei Co., Ltd. Kyushu Factory

Tateyama Kasei Co., Ltd. Kyushu Factory

Five manufacturing buildings, a quality control building, an office building, and a wastewater treatment facility are all included! It has a manufacturing license for pharmaceuticals.

Tateyama Kasei Co., Ltd.'s Kyushu factory is located in Tagawa City, which is situated in the central part of Fukuoka Prefecture. It began operations in 1972 and is equipped with five manufacturing buildings, a quality control building, an office building, and wastewater treatment facilities. Notable equipment includes an indirect cooling type ultra-low temperature reaction device and a filtration dryer. The factory holds a manufacturing license for pharmaceuticals and has two lines of 6000L active pharmaceutical ingredient purification equipment, making it suitable for the production of relatively large quantities of stable active pharmaceutical ingredients. [Features] - Possesses an indirect cooling type ultra-low temperature reaction device and a filtration dryer - Holds a manufacturing license for pharmaceuticals - Well-suited for the production of relatively large quantities of stable active pharmaceutical ingredients *For more details, please refer to the PDF document or feel free to contact us.

  • Contract manufacturing
  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Pharmaceutical CDMO services

Pharmaceutical CDMO services

We support consistent quality control from raw materials to active pharmaceutical ingredients, including method development and stability testing!

Otsuka Chemical Co., Ltd. offers pharmaceutical CDMO services. Utilizing organic synthesis technology cultivated over many years in pharmaceutical manufacturing, we provide a consistent service from special raw materials to intermediates and mid-sized active pharmaceutical ingredients. With over 60 years of experience in halogenation technology and our unique catalyst development technology, we respond to diverse needs. Please feel free to contact us when you need our services. 【Features】 ■ High pharmacological activity (OEB Category 4) with solid-phase synthesis / flow synthesis capabilities Newly established GMP-compliant multi-purpose plant ■ Consistent service from special raw materials to intermediates and mid-sized active pharmaceutical ingredients ■ Responding to diverse needs through halogenation technology and unique catalyst development technology *For more details, please refer to the PDF document or feel free to contact us.

  • 2022-06-30_14h05_58.png
  • 2022-06-30_14h06_09.png
  • 2022-06-30_14h06_15.png
  • 2022-06-30_14h06_23.png
  • 2022-06-30_14h06_32.png
  • 2022-06-30_14h06_37.png
  • 2022-06-30_14h06_45.png
  • 2022-06-30_14h06_51.png
  • 2022-06-30_14h06_58.png
  • Other contract services
  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Freeze & Go Solutions

Freeze & Go Solutions

Are you particular about the "freezing method" of pharmaceutical raw materials? It is possible to freeze and thaw raw materials more safely and securely while maintaining quality!

Of the biopharmaceutical active ingredients, 59.4% are transported in a frozen state. Therefore, the development of controllable and efficient freezing and thawing technologies is increasingly in demand. For example, in the development of COVID-19 vaccines, there has been a growing emphasis on storage and transportation methods, highlighting the necessity for these solutions. Recently, the combination of Allegro BioContainers and RoSS Technology has resulted in the development of an excellent active ingredient management solution through synergistic effects. It allows for the control of frozen active ingredients between the purification process and the formulation and filling processes, enabling stable and safe storage and transportation. Additionally, it prevents losses of active ingredients due to the breakage of frozen single-use packs, bringing the risk of loss close to 0%.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
BTB indicator (bromothymol blue solution)

BTB indicator (bromothymol blue solution)

Introducing pH measurement reagents! The pH measurement range is from 6.0 to 7.6.

The "BTB Indicator (Bromothymol Blue Solution)" is an indicator for pH measurement. By adding this product at a ratio of 0.5 mL to 10 mL of the sample water in a transparent container (or colorimetric cell for measuring devices), pH can be measured within the range of 6.0 to 7.6. It is recommended to use a pH meter to compare the color of the colorimetric plate with the color of the sample water after adding the indicator for measuring the pH value. 【Features】 ■ Add this product at a ratio of 0.5 mL to 10 mL of the sample water ■ It is recommended to use a pH meter to compare the color of the colorimetric plate with the color of the sample water after adding the indicator for measuring the pH value *For more details, please refer to the PDF document or feel free to contact us.

  • reagent

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Pharmaceutical pipeline for NASH treatment (nucleic acid medicine)

Pharmaceutical pipeline for NASH treatment (nucleic acid medicine)

Introduction of compounds expected to be developed as new NASH treatments.

At Renac Therapeutics, we handle "Pharmaceutical Pipeline NASH Therapeutics (Nucleic Acid Medicines)." Using our proprietary technology, Hetero Double-Stranded Nucleic Acid (HDO) technology, we have discovered compounds that inhibit the expression of the NASH-related gene IHH. These compounds are expected to improve the NAFLD activity score in NASH animal models by inhibiting IHH expression, paving the way for the development of a novel NASH therapeutic. [Features] - Effectively inhibits the expression of the NASH-related gene IHH. - Also suppresses the expression of fibrosis marker genes such as COL1A1, CTGF, and TIMP1, suggesting potential as a fibrosis treatment. *For more details, please refer to the PDF document or feel free to contact us.

  • Fine chemicals (compounds, derivatives, catalysts, etc.)

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COD test reagent

COD test reagent

Suitable for measuring chemical oxygen demand (COD) of various water qualities!

This test reagent is suitable for measuring the chemical oxygen demand (COD) of various water qualities, including surface water, groundwater, municipal wastewater, and industrial effluent. Please note that if the concentration of chloride ions in the sample is 1500 mg/L or higher, it may affect the measurement results, so please dilute the sample liquid with pure water before use. 【Features】 ■ Measurement Principle - Spectrophotometric method, dichromate method (CODcr) ■ Chloride Ion Interference - ≤2000 mg/L ■ Processing Time - 20 min @ 165℃ *For more details, please refer to the PDF document or feel free to contact us.

  • Testing Equipment and Devices

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Sogo Pharmaceutical Co., Ltd. Company Profile

Sogo Pharmaceutical Co., Ltd. Company Profile

We will leverage our forward-thinking creativity and technological capabilities to contribute to the future of life sciences.

Sogo Yakuco started as an active pharmaceutical ingredient manufacturer producing substances such as Sulfisozine, Sulfadimethoxine, and Taurine. Leveraging the synthetic technologies acquired through active pharmaceutical ingredients, we engage in the development and manufacturing of functional cosmetic ingredients, recording materials, and electronic materials. With the keywords "safety," "technical capability," "speed," "quality," and "environment," we strive to meet the needs of the life sciences sector with a spirit of "challenge" and continuous corporate efforts. 【Business Activities】 ■ Manufacturing, sales, and import/export of pharmaceutical active ingredients, veterinary pharmaceuticals, and functional cosmetic ingredients ■ Manufacturing, sales, and import/export of fine chemical products such as specialty chemicals and chemical industrial products *For more details, please refer to the PDF materials or feel free to contact us.

  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Exudative Age-related Macular Degeneration Clinical Trial

Exudative Age-related Macular Degeneration Clinical Trial

RBM-007 is considered a potential new treatment for wet AMD patients with no prior treatment history!

We would like to introduce the clinical trials conducted by our company. As a clinical trial targeting exudative age-related macular degeneration (wet AMD), a Phase 2 clinical trial was conducted in the United States after the implementation of a Phase 1/2a clinical trial, aimed at confirming the clinical proof of concept (POC) of multiple administrations of RBM-007. Furthermore, a physician-led clinical trial was conducted in the United States to evaluate the efficacy and safety of RBM-007 monotherapy in treatment-naive wet AMD patients. 【Main Trials】 ■ Randomized double-blind trial ■ Open-label trial ■ Physician-led clinical trial *For more details, please refer to the PDF materials or feel free to contact us.

  • Other Testing Contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Clinical Trial: Achondroplasia

Clinical Trial: Achondroplasia

RBM-007 strongly suggests that it could be a new drug for cartilage dysplasia!

We would like to introduce the clinical trials conducted by our company. The project concerning achondroplasia received support from the Japan Agency for Medical Research and Development (AMED) and began a Phase 1 trial in July 2020 at a domestic clinical trial facility to investigate the safety, tolerability, and pharmacokinetics of RBM-007, which was conducted until May 2021. Regarding the Phase 2 trial of this project, it has been adopted as a pre-commercialization support project for orphan drugs by AMED for three years starting from the fiscal year 2021. [Main Trials] ■ Phase 1 Clinical Trial ■ Early Phase 2 Observational Trial ■ Early Phase 2 Clinical Trial ■ Early Phase 2 Long-term Clinical Trial *For more details, please refer to the PDF materials or feel free to contact us.

  • Other Testing Contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.